Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy

Histone deacetylase (HDAC)-inhibitors (HDACis) are well characterized anti-cancer agents with promising results in clinical trials. However, mechanistically little is known regarding their selectivity in killing malignant cells while sparing normal cells. Gene expression-based chemical genomics iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Stankov, Metodi V., Khatib, Mona El, Thakur, Basant Kumar, Heitmann, Kirsten, Panayotova-Dimitrova, Diana, Schoening, Jennifer, Bourquin, Jean-Pierre, Schweitzer, Nora, Leverkus, Martin, Welte, Karl, Reinhardt, Dirk, Li, Zhe, Orkin, Stuart H., Behrens, Georg M.N., Klusmann, Jan-Henning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947652/
https://www.ncbi.nlm.nih.gov/pubmed/24080946
http://dx.doi.org/10.1038/leu.2013.264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947652/
https://www.ncbi.nlm.nih.gov/pubmed/24080946
http://dx.doi.org/10.1038/leu.2013.264

Ejemplares similares